Condition: CTNNB1 Neurodevelopmental Syndrome · Sponsor: University Medical Centre Ljubljana
The aim of the Dragonfly study is to characterise and monitor the neurodevelopment of children and adults diagnosed with CTNNB1 syndrome through an international collaborative effort. Gaining comprehensive understanding of the mental, physical and social development of people with CTNNB1 neurodevelopmental syndrome and how their symptoms and abilities change over time will help improve and standardize care for these patients, as well as facilitate future research and clinical trials design.
This description comes directly from the study's public registry record.
Damjan Osredkar, MD, PhD · 0038615229273 · damjan.osredkar@kclj.si
Always discuss trial participation with your own doctor first.
| Sydney Children's Hospital | Sydney, Australia | Not Yet Recruiting |
| University Medical Centre Ljubljana | Ljubljana, Slovenia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07167732